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in patients with acute coronary syndrome admitted
to a tertiary care hospital in southwest region,
Saudi ArabiaAbdullah S. Assiri a,⇑, Abdul-moneim Jamil b, Ahmed A. Mahfouz c, Zizi S. Mahmoud d,
Mohamed Ghallab ea–e College of Medicine, King Khalid University, Saudi ArabiaObjective: Identifying risk factors for acute coronary syndrome (ACS) is important for both diagnostic and
prognostic purposes. Abnormal platelet parameters, mainly platelet count (PC), mean platelet volume (MPV) and
platelet distribution width (PDW) are thought to be among these risk factors. In this study, the associations between
PC, MPV and PDW and ACS were investigated in patients admitted to the tertiary care hospital in the south west
region of Saudi Arabia.
Materials and methods: A retrospective cohort of 212 patients with the diagnosis of ACS admitted to Aseer Central
Hospital during the period extending from February 1, 2008 to October 31, 2008 were included. The control group
consisted of 49 matched subjects who were admitted for chest pain investigation and subsequently found to be
non-cardiac chest pain after performing relevant investigations. Blood samples were taken at the time of admission
for platelet parameters. Statistical analysis was made using SPSS software and P-values were considered significant
if <0.05.
Results: A total of 212 patients with acute coronary syndrome (80 patients with MI and 132 patients with UA) and
49 matched controls were studied. The PC was not statistically different among the three groups (283.3 ± 94.8 
109 L1 for MI cases, 262 ± 60.8  109 L1 for UA cases and 275.8 ± 58.9  109 L1 for controls). The MPV was signif-
icantly larger in MI cases compared to controls (8.99 ± 1.5 fl vs. 8.38 ± 0.51 fl, respectively, P < 0.009), similarly, the
MPV was significantly larger in UA cases compared to controls (9.23 ± 1.19 fl vs. 8.38 ± 0.51 fl, respectively,
P < 0.001). The PDW was significantly higher in MI cases compared to controls (15.88 ± 1.5 fl vs. 11.96 ± 1.8 fl, respec-
tively, P < 0.001), similarly, the PDW as also significantly larger in UA cases compared to controls (18.1 ± 18 fl vs.
11.96 ± 1.8 fl, respectively, P < 0.019).
Conclusion: Platelet parameters mainly MPV and PDW are readily available and relatively simple and inexpen-
sive laboratory tests which we detected to be significantly raised in patients who have suffered an acute coronary
syndrome compared with controls.
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2012;24:17–21Acute coronary syndrome (ACS) is the mostprevalent cardiac disorder, affecting over
12 millions in the United States. Each year, it is
estimated that one million individuals in the
United States suffer a coronary event [20].
Despite improvement in primary prevention
and treatment [12], acute coronary syndrome re-
mains the chief cause of death in the United States
and most developed countries [15]. Almost half of
all victims of myocardial infarction die before they
reach the hospital [9].
ACS includes myocardial infarction and
unstable angina. Diagnosing ACS is still a chal-
lenge despite the remarkable improvement in
the diagnostic modalities and physicians continue
to admit a large number of patients with chest
pain who proved to be non-cardiac patients after
thorough investigations [14].
Platelets have a major role in the pathogenesis
of ACS, where plaque rupture is followed by
platelet activation and thrombus formation lead-
ing to coronary artery occlusion [4,5,24]. Anti-
platelet agents have a cardinal role in the manage-
ment of patients with ACS. They interrupt the
pathologic cascade of thrombosis. Therefore, acet-
yl salicylic acid, thienopyridine and glycoprotein
2b/3a inhibitors, which all inhibit the platelet
function, are used in the treatment of ACS pa-
tients [18].
Platelets vary in size and activity [7,19].
When platelets are activated they become larger
in size, which can be measured by both larger
mean platelet volume (MPV) and platelet distribu-
tion width (PDW). Larger platelets are more adhe-
sive and tend to aggregate more than smaller ones
[22]. This increase in platelet volume will increase
the tendency for coronary thrombus formation in
ACS patients [6].
The Aseer region (population of 12,00,000) is lo-
cated in the southwest of Saudi Arabia covering
an area of more than 80,000 km2. The region ex-
tends from the high mountains of Sarawat (with
an altitude of 3200 m above the sea level) to the
Red Sea. Health services delivery in Aseer region
is provided by a network of 244 primary health
care centers, 16 referral hospitals and one tertiary
hospital, Aseer Central Hospital (ACH). ACH,
with 500 beds, is run by the Ministry of Health
and the College of Medicine of King Khalid Uni-
versity, Abha.
The aim of this study was to investigate whether
there is an association between platelet parame-
ters (mainly PC, MPV and PDW) and ACS in
patients admitted to the tertiary care hospital in
southwest region of Saudi Arabia.Materials and methods
Study population
A retrospective cohort of 212 consecutive
patients admitted to Aseer Central Hospital CCU
with the diagnosis of ACS during the period
extending from February 1, 2008 to October 31,
2008 were included. Diagnosis of the different
types of ACS was based on the American College
of Cardiology clinical data standards [1].
Exclusion criteria include: patients with severe
hepatic impairment, renal impairment (three
cases), patients with documented malignancy, or
on anti-inflammatory (five cases), anti-coagulants
(two cases) or anti-platelet therapy (four cases).
Patients on acetyl salicylic acid were not ex-
cluded as it does not interfere with platelet param-
eters measured [11].
The control group consisted of 49 age and sex
matched subjects who were admitted with chest
pain for investigation and found to be non-cardiac
chest pain after thorough investigations including
a normal coronary angiography, which was per-
formed for all of them.Clinical data and hematologic parameters
collections
All patients underwent a standard 12 lead ECG
examination which was interpreted by an expert
cardiologist regarding the standard ischemic
ECG changes.
Diagnosis of ACS was confirmed with typical
symptoms, ECG changes, laboratory tests and/or
coronary angiography which was performed on
130 patients (61%).
Aliquots of 2 ml blood were collected in dipotas-
sium EDTA tubes from all the patients on admis-
sion by a clean puncture. The sample was run
within 2 h of venepuncture using the Sysmex K-
4500 automated cell counter (TOA Electronics,
Koebe, Japan), then different platelet parameters
were measured including PC, MPV and PDW.Statistical analysis and ethics
Data were analyzed using SPSS software pack-
age. Frequency, percentage, mean, standard devi-
ation and median were used to present the data.
For contingency tables Chi square test was used.
The student t-test was used to assess whether
the means of two groups are statistically different
from each other. The chosen level of significance
was 5%. Approval of the local medical-ethics com-
mittee was obtained prior to the study.
Table 2. Comparison of platelet parameter values in patients
with MI and controls.
Platelet
parameter
MI Controls P-value
Platelet count
(109L1)
283.3 ± 99.8 275.81 ± 58.9 0.66
Mean platelet volume
(FL)
8.99 ± 1.5 8.38 ± 0.51 0.009
Platelet distribution
width (FL)
15.88 ± 1.5 11.96 ± 1.8 0.001
Table 3. Comparison of platelet parameter values in patients
with UA and controls.
Platelet parameter UA Controls P-value
Platelet count
(109/ L1)
262 ± 60.8 275.81 ± 58.9 0.22
Mean platelet
volume (FL)
9.23 ± 1.19 8.38 ± 0.51 0.001
Platelet distribution
width (FL)
18.1 ± 18 11.96 ± 1.8 0.019
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Clinical characteristics of the study population
A total of 212 patients with ACS [80 patients with
myocardial infarction (MI) and 132 patients with
unstable angina (US)] and 49 sex and age matched
control cases were included.
The mean age of the ACS patients was 56.59 ±
13.6 years and male gender constituted 77.4%
(164) of them. No statistically significant difference
was detected between the two groups regarding
the age or the gender distribution.
Coronary risk factors were more prevalent
among ACS cases compared to controls (Table 1).
Platelet parameters
There was no statistically significant difference
in PC between MI cases and controls (283.3 ±
94.8  109 L1 vs. 275.8 ± 58.9  109 L1, respec-
tively, P = 0.66), or between the UA cases and con-
trols (262 ± 60.8  109 L1 vs. 275.8 ± 58.9  109 L1,
respectively, P = 0.22).
The MPV was significantly larger in MI cases
compared to controls (8.99 ± 1.5 fl vs. 8.38 ±
0.51 fl, respectively, P < 0.009), similarly, the MPV
was significantly larger in UA cases compared to
controls (9.23 ± 1.19 fl vs. 8.38 ± 0.51 fl, respec-
tively, P < 0.001).
The PDW was also significantly higher in MI
cases compared to controls (15.88 ± 1.5 fl vs.
11.96 ± 1.8 fl, respectively, P < 0.001), similarly,
the PDW was significantly larger in UA cases com-
pared to controls (18.1 ± 18 fl vs. 11.96 ± 1.8 fl,
respectively, P < 0.019) (Tables 2 and 3).Discussion
Acute coronary syndrome (ACS) is a multi-fac-
torial disorder, where many endogenous andTable 1. Clinical characteristics of the study population.
Variable Controls
(49)
ACS (212) P⁄
Age: (mean ± SD)
years
58.93 ± 12.03 56.59 ± 13.630 0.647
Gender: Male: No
(%)
39 (79.6%) 164 (77.4%) 0.465
Coronary risk factors
distribution
Family History of
IHD: No (%)
7 (14.3%) 80 (37.7%) 0.001
DM: No (%) 15 (30.6%) 124 (58.5%) 0.001
Hyperlipidemia: No
(%)
8 (16.3%) 88 (41.5%) 0.001
Hypertension: No
(%)
23 (46.9%) 117 (55.2%) 0.215
Smoking: No (%) 7 (14.3%) 76 (35.8%) 0.004exogenous risk factors such as smoking, diabetes,
hypertension and hyperlipidemia increase its risk
[25]. Nevertheless, these risk factors account only
partially for all cases of ACS [2]. Therefore, other
possible risk factors need to be identified in order
to help in predicting ACS.
Generalized platelet activation occurs during
the acute coronary event, where the increase rate
of platelet consumption at the site of atheroscle-
rotic plaque rupture leads to the release of large
size platelets from the bone marrow.
This activation process results in signaling path-
ways that induce platelets to change their shape
(metamorphosis) and size [16] and become more
active in secreting thromboxane A2 and ADP into
the circulation. Larger platelets are more adhesive
and tend to aggregate more than smaller ones [22]
that contain more secretory granules and mito-
chondria and are known to be more active than
smaller platelets [17].
The release of thromboxane A2 and ADP stimu-
lates the neighboring platelets, causing them to
become activated and in turn secrete additional
thromboxane A2 and ADP.
Activated large size platelets not only secrete
thromboxane A2 and ADP but also directly bind
to the circulating coagulation protein fibrinogen,
via the abundant platelet integrin, glycoprotein
(GP) IIb/IIIa [23,3].
The platelet–fibrinogen–platelet connection ini-
tiates the process of platelet aggregation [8] and
thus, leads to coronary thrombus formation and
ACS.
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platelets as determined by their volumes, MPV,
may be useful markers in patients with ACS.
In this study we examined the relationship be-
tween platelet parameters mainly PC, MPV and
PDW and the occurrence of ACS in patients from
the southwest region of Saudi Arabia. We found that
patients with ACS (both MI and US) tend to have
significantly larger MPV and PDW (which both re-
flect the platelet volume) than the control group.
While no statistically significant difference was de-
tected regarding the PC between the three groups.
Recently Lippi et al. have demonstrated in a
large scale study that MPV at admission is higher
in ACS compared to those with chest pain of non-
cardiac origin [13].
Likewise, similar observations were made by
other investigators, where MPV was found to be
higher in patients with ACS compared to healthy
controls [10,21].
Inourcohortwedidnotdetectastatisticallysignifi-
cant difference regarding the PC among the three
groups,similarobservationwasfoundbyotherinves-
tigatorsinalargerscalestudy[13].Whileotherstudies
although,smallerinsamplesize,reportedthePCtobe
lower while MPV to be higher in ACS patients com-
paredtothecontrols[10,21].
This discrepancy in findings regarding the PC
level and agreement on findings regarding the
platelet volume parameters among different stud-
ies in ACS patients might indicate that the platelet
volume indices rather than the platelet count are
more important in determining the risk of devel-
oping ACS.Conclusion
We concluded that platelet volume parameters
mainly MPV and PDW are readily available,
relatively inexpensive and useful markers which
we detected to be significantly raised in the pa-
tients admitted with ACS to the tertiary care hos-
pital in the southwest region of Saudi Arabia
compared to the controls. And thus should be uti-
lized with other investigational tools to screen pa-
tients presenting to the emergency room with
chest pain who are suspected to have ACS.References
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